II. Indications
- Serious Gram Negative Bacterial infection
- Use alone or in combination with Aminoglycosides
III. Medications
- Alpha carboxy Penicillin
- Carbenicillin
- Discontinued in U.S. as of 2008
- Ticarcillin (Ticar)
- Withdrawn from U.S. market as of 2015
- Ticarcillin clavulanate (Timentin)
- Withdrawn from U.S. market as of 2015
- Carbenicillin
- Acylamino-Penicillin
- Mezlocillin (Mezlin)
- Discontinued in U.S.
- Piperacillin (Pipracil)
- Not typically used without tazobactam
- Piperacillin Tazobactam (Zosyn)
- Only Extended Spectrum Penicillin still available in the United States as of 2023
- Mezlocillin (Mezlin)
- Other structures
- Pivmecillinam (Selexid, Pivya)
- FDA approved in 2024 for simple cystitis in women
- Pivmecillinam (Selexid, Pivya)
IV. Mechanism
- Similar to Natural Penicillins
- Greater penetration through Gram Negative membrane
- High affinity for Penicillin binding Proteins
- Beta lactamase resistance with Clavulanate, Tazobactam
V. Mechanism: Bacterial Resistance
- Beta lactamase (except with Clavulanate or Tazobactam)
- Alteration of Penicillin binding Proteins (Pseudomonas)
VI. Dosing: Parenteral
-
Piperacillin Tazobactam (Zosyn)
- Adult: 3.375 g IV q6 hours
- Ticarcillin Clavulanate (Timentin, not available in U.S.)
- Listed for historical purposes, and for use outside the U.S.
- Adult: 3.1 g IV q4-6h
- Child: 50 mg/kg up to 3.1 g IV q4-6 hours
VII. Adverse Effects
- Many side effects in addition to Natural Penicillins
- High Sodium load (Carbenicillin)
- Platelet Dysfunction
VIII. Activity Spectrum
- Similar to Natural Penicillins and Aminopenicillins
- Expanded Gram Negative coverage